Brant Point Investment Management LLC Ligand Pharmaceuticals Inc Transaction History
Brant Point Investment Management LLC
- $406 Million
- Q3 2024
A detailed history of Brant Point Investment Management LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Brant Point Investment Management LLC holds 200 shares of LGND stock, worth $22,676. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200Holding current value
$22,676% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding LGND
# of Institutions
256Shares Held
18.1MCall Options Held
26.8KPut Options Held
9.3K-
Black Rock Inc. New York, NY2.87MShares$326 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.97MShares$223 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.01MShares$114 Million0.05% of portfolio
-
Macquarie Group LTD Australia, C3887KShares$101 Million0.1% of portfolio
-
State Street Corp Boston, MA707KShares$80.2 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.91B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...